Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-000046

CHIEF MEDICAL OFFICER acquired 2,655 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Mark Alan CHIEF MEDICAL OFFICER 2021-12-31 Grant or award +2,655 $1.66 $4,401 14,915 D
Loading xslF345X03/form4-01032022_010104.xml…